Get started
Author

H Löhr

Observed names: H. F. Löhr, H. Löhr, HF Löhr
Institution: Lundbeck (Germany)
OpenAlex ID: A5050098300
Interleukin‐2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon‐α plus ribavirin
2003 · A. P. Barreiros, J. F. Schlaak, et al. · European Journal of Clinical Investigation · 4
Septische Verlaufsformen von Yersinia-enterocolitica-Infektionen bei gesunden und chronisch kranken Kindern
2008 · S. Strobel, H. Löhr, et al. · DMW - Deutsche Medizinische Wochenschrift · 3
Daily consensus interferon versus peg-interferon alfa2b with weight based ribavirin in treatment-naive patients with chronic hepatitis C serotype-1
2007 · M Schuchmann, H Löhr, et al. · Zeitschrift für Gastroenterologie · 2
SLA positive autoimmune hepatitis (AIH) behaves clinically, histologically and biochemically as ANA positive AIH
1998 · S Kanzler, C Weidemann, et al. · Journal of Hepatology · 1
Edukation bei chronischen Kopfschmerzen durch Übergebrauch von Schmerz- und Migränemitteln
2025 · Hans-Christoph Diener, M. Graf, et al. · Der Schmerz
PDF
Boceprevir triple therapy of chronic HCV genotype 1 (G1) infection in previously untreated patients: Efficacy, predictability of virologic response and safety in German real-life
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Treatment of chronic HCV Genotype 1 infection with Boceprevir in German real-life:The impact of SVR on initially elevated and initially normal serum alanine aminotransferase (ALT) and gamma-glutamyl transpeptidase (GGT) levels
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Boceprevir triple therapy of HCV genotype 1 (G1) infection in German real-life: comparable high SVR rates up to 87% in treatment-naïve and previously treated patients who achieve an early virologic response
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Baseline gamma-GT levels within the normal range predict high virologic response rates in treatment-naïve patients undergoing boceprevir triple therapy for HCV genotype 1 (G1) infection
2015 · P Buggisch, HF Löhr, et al. · Zeitschrift für Gastroenterologie
Treatment of previously untreated patients with chronic HCV genotype 1 infection with boceprevir in German real-life: high end of treatment response of 95% in patients with early virologic response
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life
2015 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life
2014 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response
2014 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Treatment of chronic Hepatitis C Genotype 1 (G1) infection with Boceprevir (BOC) in German Real-Life: Impact of Hemoglobin (Hb) decline on virologic response
2014 · G Teuber, P Buggisch, et al. · Zeitschrift für Gastroenterologie
Changes of demographic- and disease characteristics of patients with chronic HCV genotype 1 infection In Germany during the past decade
2013 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie
Wirksamkeit von Tenofovir (TDF) bei chronischer Hepatitis B (CHB) in der klinischen Praxis - 2 Jahres Daten der Deutschen Pprspektiven Multizentrischen nicht-Interventionellen Studie (NIS) „GEMINIS“
2013 · J Petersen, R Heyne, et al. · Zeitschrift für Gastroenterologie
Interim results from the PACT-trial: High antiviral efficacy of daily consensus interferon/ribavirin compared to peg-interferon alfa2b/ribavirin in treatment-naive patients with chronic hepatitis C and serotype–2 or –3
2005 · WO Böcher, M Fuchs, et al. · Zeitschrift für Gastroenterologie
Prospektiv randomisierte Dosisfindungsstudie für Ribavirin in Kombination mit Interferona2b zur Ersttherapie der chronischen HCV-Infektion
2004 · WO Böcher, M Sprinzl, et al. · Zeitschrift für Gastroenterologie
Retrospektive Kohortenstudie zur Lamivudintherapie bei Patienten mit chronischer Hepatitis B
2001 · G Teuber, H Löhr, et al. · DMW - Deutsche Medizinische Wochenschrift
Works count: 20
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type